MD Anderson

Shane Leonard, a talented young man with his whole life ahead of him, did not let cancer create despair. Instead, Shane looked for opportunities in his new cancer hospital surroundings to inspire his future. At 17, cancer was found in his salivary gland. After surgery, he came to The University of Texas MD Anderson Cancer Center for follow-up proton radiation treatment. In Shane's spare time, he would study quantum mechanics lectures and became friends with the senior medical physicist of the...

CYCORE (Cyberinfrastructure for Comparative Effectiveness Research) was a clinical trial conducted by The University of Texas MD Anderson Cancer Center, University of California-San Diego and University of Alabama at Birmingham, that studied the use of sensing devices to wirelessly send health-related data from the patient’s home to the cancer research facility. The purpose of this study is for other researchers to use CYCORE’s technology to gather more detailed information in their own...

Download from iTunes: http://bit.ly/uus4tw The number of new throat cancer cases in the United States has jumped by 125% in the last two decades. The main reason for this alarming increase in throat cancer HPV (Human Papillomavirus), the same virus that causes cervical cancer. Floyd Christopher Holsinger, M.D., Associate Professor of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center, discusses this topic as well as other causes, diagnoses, and treatment options for...

There were about 1,970 new cases of invasive breast cancer diagnosed among men in the United States in 2010. Yet, because of the lack of awareness, diagnosis normally happens at a late stage. Breast cancer is branded a female disease, so males must brave the pink ribbons, women-only waiting rooms, etc. There are similarities and differences in male and female breast cancer. Sharon Giordano, M.D., associate professor and internist in the Department of Breast Medical Oncology at MD...

MD Anderson's Dr. Michelle Fanale, Hodgkin lymphoma survivor Alexandra Medina and research nurse Rinata Simien talk about newly approved drug brentuximab vedotin.

Vulvar cancer is rare, with around 4,000 women in the United States diagnosed each year. Doctors often misdiagnose vulvar cancer as an abscess, but if caught early it is highly curable with little disfigurement or sexual dysfunction. Charles Levenback, M.D., and Anuja Jhingran, M.D., both professors in the Department of Gynecologic Oncology at the University of Texas MD Anderson Cancer Center, discuss the basics, diagnoses and treatment of vulvar cancer.

Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Learn what exams and guidelines the American Cancer Society recommends for prostate cancer screening.

"Without regular colonoscopies and the great treatment I received at MD Anderson, I would be dead," says Renato Lenzi, M.D., clinical associate professor in GI Medical Oncology. After he was diagnosed with colon cancer in 2002 during a screening, Lenzi endured months of treatment that included surgery, six months of chemotherapy and five weeks of chemotherapy with radiation. This cancer warrior is being recognized by his colleagues as the honoree of the 2011 Sprint for Colorectal Cancer...

Jennifer Litton M.D. makes sense of hormone replacement therapy and its relationship to your risk of getting breast cancer. Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Dr. Jennifer Litton, Assistant Professor of Breast Medical Oncology, at The University of Texas MD Anderson Cancer Center discusses hormone replacement therapy and breast cancer risk. View other videos at www.mdanderson.org/videos

It was a big day for MD Anderson at yesterday's legislative session in Austin. To mark the institution's 70th anniversary, two members of the Texas legislature presented a resolution recognizing MD Anderson for its remarkable achievements in cancer care that span seven decades. Texas Rep. Sarah Davis shares her thoughts on the resolution.